- Abstract
- Core Tip
- Article Highlights
- Full Article with Cover (PDF)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (598)
- Timeline of Article Publication (1)
- Authors Evaluation (4)
- Article Quality Tracking (2)
- Reader Comments (1)
- Reference Citation Analysis (2)
Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6763)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 5, 2022 (publication date) through Jul 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
2022 | Number of total visits
| Rank | Countries/Territories | Count | Percent |
| 1 | United States | 234 | 36.4% |
| 2 | China | 98 | 15.2% |
| 3 | Russia | 56 | 8.7% |
| 4 | Brazil | 46 | 7.2% |
| 5 | Netherlands | 45 | 7% |
| 6 | Australia | 26 | 4% |
| 7 | France | 23 | 3.6% |
| 8 | Taiwan | 22 | 3.4% |
| 9 | Korea, Republic of | 18 | 2.8% |
| 10 | Germany | 17 | 2.6% |
| 11 | Canada | 16 | 2.5% |
| 12 | Italy | 6 | 0.9% |
| 13 | India | 5 | 0.8% |
| 14 | Finland | 5 | 0.8% |
| 15 | Japan | 3 | 0.5% |
| 16 | Denmark | 3 | 0.5% |
| 17 | Estonia | 3 | 0.5% |
| 18 | United Kingdom | 3 | 0.5% |
| 19 | Turkey | 2 | 0.3% |
| 20 | Slovakia | 2 | 0.3% |
| 21 | Ireland | 2 | 0.3% |
| 22 | Iran, Islamic Republic of | 1 | 0.2% |
| 23 | Romania | 1 | 0.2% |
| 24 | Hong Kong | 1 | 0.2% |
| 25 | Argentina | 1 | 0.2% |
| 26 | Spain | 1 | 0.2% |
| 27 | Sweden | 1 | 0.2% |
| 28 | Singapore | 1 | 0.2% |
| 29 | Ukraine | 1 | 0.2% |